Back to Search
Start Over
Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases
- Source :
- Clinical and Translational Allergy, Clinical and Translational Allergy, BioMed Central, 2019, 9 (1), ⟨10.1186/s13601-019-0242-2⟩, Clinical and Translational Allergy, 2019, 9 (1), ⟨10.1186/s13601-019-0242-2⟩, Clinical and translational allergy, London : BMC, 2019, vol. 9, art. no. 7, p. [1-10], Clinical and Translational Allergy, Vol 9, Iss 1, Pp 1-10 (2019)
- Publication Year :
- 2019
- Publisher :
- HAL CCSD, 2019.
-
Abstract
- Background Over 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea. Conclusion The Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.
- Subjects :
- Allergy
IMPACT
Chronic rhinosinusitis
Declaration
Review
Chronic respiratory diseases
DECISION-MAKING
[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract
0302 clinical medicine
Vilnius Declaration
11. Sustainability
Immunology and Allergy
030212 general & internal medicine
[SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology
mHealth
Rhinitis
COPD
CLIMATE-CHANGE
Self-management
3. Good health
air pollution
asthma
chronic respiratory diseases
guidelines
integrated care pathways
rhinitis
Integrated care pathways
Christian ministry
HEALTH
Life Sciences & Biomedicine
[SDV.IMM.ALL] Life Sciences [q-bio]/Immunology/Allergology
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Immunology
Air pollution
Guidelines
OBSTRUCTIVE PULMONARY-DISEASE
VALIDATION
03 medical and health sciences
medicine
Intensive care medicine
Asthma
Science & Technology
business.industry
Public health
ALLERGY PROGRAM 2008-2018
RC581-607
medicine.disease
PREVENTION
030228 respiratory system
13. Climate action
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
[SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Immunologic diseases. Allergy
business
Subjects
Details
- Language :
- English
- ISSN :
- 20457022
- Database :
- OpenAIRE
- Journal :
- Clinical and Translational Allergy, Clinical and Translational Allergy, BioMed Central, 2019, 9 (1), ⟨10.1186/s13601-019-0242-2⟩, Clinical and Translational Allergy, 2019, 9 (1), ⟨10.1186/s13601-019-0242-2⟩, Clinical and translational allergy, London : BMC, 2019, vol. 9, art. no. 7, p. [1-10], Clinical and Translational Allergy, Vol 9, Iss 1, Pp 1-10 (2019)
- Accession number :
- edsair.doi.dedup.....7fa1454090754fe01139ceffd3d883b0